Epigallocatechin-3-gallate inhibits LPS-induced NF-κB and MAPK signaling pathways in bone marrow-derived macrophages

Gut and Liver

Volumn 6, Issue 2, 2012, Pages 188-196

  Joo, So Young ^a   Song, Young A ^a   Park, Young Lan ^a   Myung, Eun ^a   Chung, Cho Yun ^a   Park, Kang Jin ^a   Cho, Sung Bum ^a   Lee, Wan Sik ^a   Kim, Hyun Soo ^a   Rew, Jong Sun ^a   Kim, Nack Sung ^a   Joo, Young Eun ^a  

^a Chonnam National University   (South Korea)

Author keywords

Epigallocatechin 3 gallate; Macrophage; Mitogen activated protein kinase; Nuclear factor B

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BACTERIUM LIPOPOLYSACCHARIDE; EPIGALLOCATECHIN GALLATE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12P40; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR RELA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOACCUMULATION; BONE MARROW DERIVED MACROPHAGE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENTERITIS; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; IMMUNOFLUORESCENCE; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TEA; WESTERN BLOTTING;

EID: 84860349530     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2012.6.2.188     Document Type: Article

References (46)

1. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004;(343):1-19.
2. Barnes PM, Adams PF, Powell-Griner E. Health characteristics of the Asian adult population: United States, 2004-2006. Adv Data 2008;(394):1-22.
3. Chen D, Milacic V, Chen MS, et al. Tea polyphenols, their biological effects and potential molecular targets. Histol Histopathol 2008;23:487-496. (Pubitemid 351552334)
4. Khan N, Mukhtar H. Tea polyphenols for health promotion. Life Sci 2007;81:519-533. (Pubitemid 47212236)
5. Khan N, Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 2008;269:269-280.
6. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 2006;66:2500-2505.
7. Sarkar FH, Li Y, Wang Z, Kong D. Cellular signaling perturbation by natural products. Cell Signal 2009;21:1541-1547.
8. Dharmani P, Chadee K. Biologic therapies against inflammatory bowel disease: A dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Curr Mol Pharmacol 2008;1:195-212.
9. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117:514-521. (Pubitemid 46348505)
10. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434. (Pubitemid 47123518)
11. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-594. (Pubitemid 351173057)
12. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-867. (Pubitemid 36019639)
13. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-874. (Pubitemid 36019640)
14. Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK. Role of cytokines in inflammatory bowel disease. World J Gastroenterol 2008;14:4280-4288.
15. Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 2000;6:21-33.
16. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85-94. (Pubitemid 32222977)
17. Magness ST, Jijon H, Van Houten Fisher N, et al. In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J Immunol 2004;173:1561-1570. (Pubitemid 38971585)
18. Karrasch T, Jobin C. NF-kappaB and the intestine: Friend or foe? Inflamm Bowel Dis 2008;14:114-124.
19. Perkins ND, Gilmore TD. Good cop, bad cop: The different faces of NF-kappaB. Cell Death Differ 2006;13:759-772.
20. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004;18:2195-2224.
21. Kong AN, Yu R, Chen C, Mandlekar S, Primiano T. Signal transduction events elicited by natural products: Role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res 2000;23:1-16.
22. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995;9:726-735.
23. Karrasch T, Kim JS, Muhlbauer M, Magness ST, Jobin C. Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J Immunol 2007;178:6522-6532. (Pubitemid 46717436)
24. Davé SH, Tilstra JS, Matsuoka K, et al. Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide. J Immunol 2007;179:7852-7859.
25. Jobin C, Haskill S, Mayer L, Panja A, Sartor RB. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol 1997;158:226-234. (Pubitemid 127483860)
26. Haller D, Russo MP, Sartor RB, Jobin C. IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gramnegative enteric bacteria-induced RelA phosphorylation and NFkappa B activation in both primary and intestinal epithelial cell lines. J Biol Chem 2002;277:38168-38178. (Pubitemid 35154670)
27. Kong AN, Owuor E, Yu R, et al. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab Rev 2001;33:255-271. (Pubitemid 33136265)
28. Liu J, Hong S, Feng Z, et al. Regulation of lipopolysaccharideinduced inflammatory response by heat shock protein 27 in THP-1 cells. Cell Immunol 2010;264:127-134.
29. Sánchez-Fidalgo S. Cpolysaccharide-induced inflammatory response by heat shock protein 27 in THP-1 cells. Cell Immunol 2010;264:127-134. lemmmation in mice. Eur J Pharmacol 2010;633:78-84.
30. Sheng KC, Pietersz GA, Tang CK, Ramsland PA, Apostolopoulos V. Reactive oxygen species level defines two functionally distinctive stages of inflammatory dendritic cell development from mouse bone marrow. J Immunol 2010;184:2863-2872.
31. Chambers TJ, Owens JM, Hattersley G, Jat PS, Noble MD. Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proc Natl Acad Sci U S A 1993;90:5578-5582. (Pubitemid 23176204)
32. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A 1989;86:2336-2340. (Pubitemid 19102503)
33. Calixto JB, Campos MM, Otuki MF, Santos AR. Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 2004;70:93-103. (Pubitemid 38299768)
34. Yang F, Oz HS, Barve S, et al. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol 2001;60:528-533. (Pubitemid 32781560)
35. Porath D, Riegger C, Drewe J, Schwager J. Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines. J Pharmacol Exp Ther 2005;315:1172-1180. (Pubitemid 41635405)
36. Navarro-Perán E, Cabezas-Herrera J, Sánchez-Del-Campo L, García-Cánovas F, Rodríguez-López JN. The anti-inflammatory and anti-cancer properties of epigallocatechin-3-gallate are mediated by folate cycle disruption, adenosine release and NF-kappaB suppression. Inflamm Res 2008;57:472-478.
37. Ichikawa D, Matsui A, Imai M, Sonoda Y, Kasahara T. Effect of various catechins on the IL-12p40 production by murine peritoneal macrophages and a macrophage cell line, J774.1. Biol Pharm Bull 2004;27:1353-1358. (Pubitemid 41701674)
38. Melgarejo E, Medina MA, Sánchez-Jiménez F, Urdiales JL. Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro. Br J Pharmacol 2009;158:1705-1712.
39. Rogers J, Perkins I, van Olphen A, et al. Epigallocatechin gallate modulates cytokine production by bone marrow-derived dendritic cells stimulated with lipopolysaccharide or muramyldipeptide, or infected with Legionella pneumophila. Exp Biol Med (Maywood) 2005;230:645-651. (Pubitemid 41506859)
40. Ahn SC, Kim GY, Kim JH, et al. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. Biochem Biophys Res Commun 2004;313:148-155.
41. Ran ZH, Chen C, Xiao SD. Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomed Pharmacother 2008;62:189-196. (Pubitemid 351391979)
42. Abboud PA, Hake PW, Burroughs TJ, et al. Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. Eur J Pharmacol 2008;579:411-417.
43. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997;89:1881-1886. (Pubitemid 28009824)
44. Cao Y, Cao R. Angiogenesis inhibited by drinking tea. Nature 1999;398:381.
45. Kundu JK, Surh YJ. Epigallocatechin gallate inhibits phorbol esterinduced activation of NF-kappa B and CREB in mouse skin: Role of p38 MAPK. Ann N Y Acad Sci 2007;1095:504-512. (Pubitemid 47092481)
46. Chen L, Zhang HY. Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. Molecules 2007;12:946-957.